Annovis Bio, Inc.
(NYSE Amex Equities : ANVS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.60%123.280.7%$1936.14m
PFEPfizer Inc. -2.71%30.890.9%$1431.38m
MRKMerck & Co., Inc. -2.49%71.700.7%$1293.00m
ABBVAbbVie, Inc. -1.73%72.552.3%$1211.13m
BMYBristol-Myers Squibb Co. 1.07%52.811.0%$1063.11m
LLYEli Lilly & Co. -0.23%134.041.1%$895.93m
FTSVForty Seven, Inc. 0.09%94.550.0%$324.65m
NVSNovartis AG -0.51%79.330.2%$314.08m
GSKGlaxoSmithKline Plc -2.09%36.470.2%$276.86m
AZNAstraZeneca Plc 0.31%42.491.2%$268.45m
NVONovo Nordisk A/S 1.21%56.650.1%$166.60m
SNYSanofi -1.19%42.440.2%$158.34m
BHCBausch Health Cos., Inc. -6.28%14.470.0%$103.86m
RGENRepligen Corp. 1.25%92.557.1%$72.48m
RETAReata Pharmaceuticals, Inc. 0.73%149.993.4%$67.52m

Company Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.